Qilu Antibiotics Company Profile
✉ Email this page to a colleague
What is the competitive landscape for QILU ANTIBIOTICS
QILU ANTIBIOTICS has six approved drugs.
Summary for Qilu Antibiotics
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 6 |
Drugs and US Patents for Qilu Antibiotics
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qilu Antibiotics | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 203702-004 | Jun 29, 2016 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Qilu Antibiotics | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INJECTION | 209218-001 | Oct 17, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Qilu Antibiotics | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 203661-002 | Mar 11, 2022 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
